Amedica Drug Screen Test Cup
510(k) K082898
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK082898 | Date19 Dec 2008 | StatusActive |
Recalls
-
- Terminated Z-0270-2019
Product was released to market without the adulteration strip included in the product.
-
- Terminated Z-2311-2016
Branan Medical is recalling the AmediCheck Instant Test Cup, a 5 panel drug cup, because it may erroneously contain 12 panel cups due to a packaging error.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- NGL
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.3650
- Advisory Committee
- Clinical Toxicology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
The Amedica Drug Screen Test Cup is an in vitro diagnostic device designed for the rapid, qualitative detection of drugs of abuse in human urine. It employs lateral flow immunoassay technology to identify multiple substances, including opiates, cocaine, THC, amphetamines, methamphetamines, PCP, MDMA, barbiturates, and benzodiazepines, among others, based on the provided registration numbers.
This single-use, over-the-counter device is intended for use in clinical toxicology settings. Supplied as a sterile, ready-to-use cup, it requires no additional preparation beyond the introduction of a urine sample. The device is classified as Class II under FDA regulations (regulation number 862.3650) and holds a 510(k) clearance (K082898) for substantial equivalence, ensuring compliance with FDA standards for in vitro diagnostic devices.
Other devices from Amedica Biotech, Inc.
Questions
AI-generated answers, 19 Sep 2026
What substances does the Amedica Drug Screen Test Cup detect in urine samples, and how does it work?
The Amedica Drug Screen Test Cup uses lateral flow immunoassay technology to rapidly and qualitatively detect multiple drugs of abuse in human urine, including opiates, cocaine, THC, amphetamines, methamphetamines, PCP, MDMA, barbiturates, and benzodiazepines. It provides a simple, no-prep solution by requiring only the introduction of a urine sample into the sterile, ready-to-use cup for results.
Is the Amedica Drug Screen Test Cup intended for single-use or reusable applications?
The Amedica Drug Screen Test Cup is explicitly designed for single-use only. Each cup is sterile and ready-to-use, eliminating the need for preparation or reuse, which helps ensure accuracy and prevent cross-contamination in clinical toxicology settings.
How should the Amedica Drug Screen Test Cup be stored, and does it require any special handling?
While the device is supplied sterile and ready-to-use, storage conditions are not explicitly detailed in the provided data. However, as a single-use, over-the-counter diagnostic tool, it should be stored in a clean, dry environment away from direct sunlight or extreme temperatures to maintain its integrity until use.
What regulatory pathway was followed for FDA clearance of this device, and what does that mean for its use?
The Amedica Drug Screen Test Cup received FDA 510(k) clearance (K082898) under the Traditional 510(k) review pathway, demonstrating substantial equivalence to a predicate device. This clearance confirms compliance with FDA standards for in vitro diagnostic devices classified as Class II, ensuring its suitability for clinical toxicology applications as intended.